Purchases and Sales Made in Q1 2023 in Calliditas Therapeutics Ab (CALT)
This table provides information about the institutional ownership of Calliditas Therapeutics Ab (CALT) during Q1 2023. The information is specifically focused on institutions that hold shares of Calliditas Therapeutics AB.
Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
---|---|---|---|---|---|---|---|
May 15, 2023
Q1 2023
|
Deutsche Bank Ag\
Frankfurt Am Main, 2M |
BUY
|
- |
19K+ 26.53% |
$319K - $479K
|
90.5K
$3.62M
|
|
May 15, 2023
Q1 2023
|
Ironwood Investment Management LLC
Boston, MA |
BUY
|
- |
1.49K+ 5.65% |
$25K - $37.5K
|
27.8K
$1.11M
|
|
May 12, 2023
Q1 2023
|
Group One Trading, L.P.
Chicago, IL |
BUY
|
- |
705New |
$11.8K - $17.8K
|
705
$28.2K
|
|
Aug 14, 2024
Q1 2023
|
Federation Des Caisses Desjardins Du Quebec
Levis, A8 |
BUY
|
- |
500+ 48.31% |
$8.4K - $12.6K
|
1.54K
$61.4K
|
|
May 12, 2023
Q1 2023
|
Bank Of America Corp
Charlotte, NC |
BUY
|
- |
88+ 42.31% |
$1.48K - $2.22K
|
296
$11.8K
|
|
Oct 17, 2023
Q1 2023
|
Nalls Sherbakoff Group, LLC
Knoxville, TN |
BUY
|
- |
35New |
$588 - $883
|
35
$1.4K
|
|
May 15, 2023
Q1 2023
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
May 15, 2023
Q1 2023
|
Morgan Stanley
New York, NY |
SELL
|
- |
-51- 3.55% |
$857 - $1.29K
|
1.39K
$55.5K
|
|
May 12, 2023
Q1 2023
|
Ubs Group Ag
|
SELL
|
- |
-143- 31.85% |
$2.4K - $3.61K
|
306
$12.2K
|
|
May 11, 2023
Q1 2023
|
Optiver Holding B.V.
Amsterdam, P7 |
SELL
|
- |
-6.11K- 54.86% |
$103K - $154K
|
5.03K
$201K
|